Edwards Lifesciences Corporation (NYSE:EW) VP Sells 18960 Shares

Marco Green
September 15, 2017

Spirit of America Management Corp NY acquired a new stake in Edwards Lifesciences Corporation during the third quarter worth about $121,000. The Gilder Gagnon Howe & Co Llc holds 19,922 shares with $1.87M value, up from 6,444 last quarter.

Marble Harbor Investment Counsel LLC boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW) by 0.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The stock decreased 2.51% or $2.88 during the last trading session, reaching $111.78.

The share price of Edwards Lifesciences Corporation (NYSE:EW) was unchanged +0.00% during the last trading session, with a day high of 115.61. It has outperformed by 15.97% the S&P500. During the same quarter in the previous year, the business earned $0.76 EPS. Financial Counselors Inc. now owns 13,637 shares of the medical research company's stock worth $1,283,000 after acquiring an additional 282 shares during the period. The stock rose 0.39% or $0.03 reaching $7.78. About shares traded. U.S. Bancorp (NYSE:USB) has risen 23.07% since September 15, 2016 and is uptrending. It has outperformed by 0.35% the S&P500. Zacks Investment Research downgraded shares of Edwards Lifesciences Corporation from a "buy" rating to a "hold" rating in a research note on Thursday, June 8th. Therefore 75% are positive. BidaskClub upgraded shares of Edwards Lifesciences Corporation from a "buy" rating to a "strong-buy" rating in a research note on Thursday, June 22nd. Maxim Group maintained Landec Corporation (NASDAQ:LNDC) rating on Tuesday, July 18. The target price by Jefferies would suggest a potential upside of 8.39 % from the company's current stock price. The firm earned "Buy" rating on Thursday, January 21 by Suntrust Robinson. The rating was maintained by Oppenheimer on Friday, June 23 with "Buy". The stock of Landec Corporation (NASDAQ:LNDC) has "Hold" rating given on Wednesday, July 26 by Wedbush.

Since March 14, 2017, it had 1 buying transaction, and 0 insider sales for $278,000 activity. (NASDAQ:SYNT) for 116,744 shares. GODRIDGE LESLIE V sold 14,192 shares worth $740,539. Shares for $42,350 were sold by FRANK FRED on Tuesday, April 11. About shares traded. PROS Holdings, Inc.

Sparton Corporation is a provider of design, development and manufacturing services for electromechanical devices, as well as engineered products complementary to the same electromechanical value stream. The company has market cap of $1.34 billion. The Firm licenses technology applications to partners. It has a 65.27 P/E ratio.

Investors sentiment increased to 1.39 in Q4 2016. Its up 0.10, from 0.97 in 2016Q3. Its down 6.51% from 4.57 million shares previously. 10 funds opened positions while 26 raised stakes. Commercial Bank Of Nova Scotia invested in 0.01% or 32,900 shares. (NASDAQ:SYNT). Fort Ltd Partnership has 0.65% invested in Syntel, Inc. Tompkins Corporation invested 0% in Landec Corporation (NASDAQ:LNDC).

Qs Llc holds 4 shares or 0% of its portfolio. Martingale Asset L P owns 66,706 shares. Congress Asset Management Ma reported 26,778 shares. Susquehanna International Llp reported 0% stake.

Great Point Partners Llc holds 3.88% of its portfolio in TherapeuticsMD Inc for 3.28 million shares. Blackrock Institutional Trust Comm Na holds 724,786 shares. Stifel Nicolaus maintained PROS Holdings, Inc. (NYSE:PRO) or 60,800 shares. Alliance Data Systems Corp (NYSE:ADS) was raised too.

Among 13 analysts covering Integra Lifesciences Holdings Corp. The firm has "Neutral" rating given on Monday, April 18 by Robert W. Baird. Therefore 77% are positive. The stock has "Outperform" rating by Raymond James on Wednesday, July 29. Edwards Lifesciences Corporation presently has a consensus recommendation of "Buy" and an consensus price target of $120.75. The company was maintained on Monday, September 11 by Piper Jaffray. BMO Capital Markets restated a "buy" rating and set a $132.00 price objective on shares of Edwards Lifesciences Corporation in a research report on Friday, September 1st. On Tuesday, January 3 the stock rating was maintained by Barclays Capital with "Overweight". Cowen & Co maintained the shares of EW in report on Wednesday, December 7 with "Outperform" rating. The firm has "Equal-Weight" rating by Barclays Capital given on Thursday, July 27.

Moreover, Bard Associates Inc has 1.58% invested in the company for 142,560 shares. Its down 5.62, from 6.76 in 2016Q3. It increased, as 46 investors sold USB shares while 425 reduced holdings.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Shine Investment Advisory Services Inc. purchased a new position in shares of Edwards Lifesciences Corporation during the 2nd quarter valued at $126,000. Tower Research Capital Ltd Liability Com (Trc) reported 775 shares stake. Bancorporation Of Montreal Can holds 4,573 shares or 0% of its portfolio. 69,200 were accumulated by Sectoral Asset Management Incorporated. Fdx has invested 0.01% in Integra Lifesciences Holdings Corp (NASDAQ:IART). Morgan Stanley has invested 0% of its portfolio in PROS Holdings, Inc. Kcg accumulated 9,776 shares. Kbc Gp Nv holds 83,556 shares. It improved, as 4 investors sold PROS Holdings, Inc. shares while 31 reduced holdings. Pax Ww Mngmt Lc stated it has 350,296 shares or 0.39% of all its holdings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for with MarketBeat.com's FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article